Gillian L. Schauer

5.1k total citations · 2 hit papers
78 papers, 3.9k citations indexed

About

Gillian L. Schauer is a scholar working on Physiology, Pharmacology and General Health Professions. According to data from OpenAlex, Gillian L. Schauer has authored 78 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Physiology, 41 papers in Pharmacology and 20 papers in General Health Professions. Recurrent topics in Gillian L. Schauer's work include Smoking Behavior and Cessation (51 papers), Cannabis and Cannabinoid Research (40 papers) and Substance Abuse Treatment and Outcomes (16 papers). Gillian L. Schauer is often cited by papers focused on Smoking Behavior and Cessation (51 papers), Cannabis and Cannabinoid Research (40 papers) and Substance Abuse Treatment and Outcomes (16 papers). Gillian L. Schauer collaborates with scholars based in United States, Canada and Australia. Gillian L. Schauer's co-authors include Ann Malarcher, Carla J. Berg, Kat Asman, Stephen Babb, Ahmed Jamal, Michelle C. Kegler, Erica N. Peters, Michael Windle, Brian A. King and Timothy A. McAfee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and CHEST Journal.

In The Last Decade

Gillian L. Schauer

78 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quitting Smoking Among Adults — United States, 2000–2015

2017 832 citations Ann Malarcher, Gillian L. Schauer et al. profile →
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014

2016 341 citations Gillian L. Schauer, Althea M. Grant et al. profile →

Peers

Countries citing papers authored by Gillian L. Schauer

Since Specialization

Citations

This map shows the geographic impact of Gillian L. Schauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian L. Schauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian L. Schauer more than expected).

Fields of papers citing papers by Gillian L. Schauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian L. Schauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian L. Schauer. The network helps show where Gillian L. Schauer may publish in the future.

Co-authorship network of co-authors of Gillian L. Schauer

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian L. Schauer. A scholar is included among the top collaborators of Gillian L. Schauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian L. Schauer. Gillian L. Schauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access	Addictive Behaviors	Erin A. McClure, Leah Hamilton et al.	5
2	A Research Agenda to Inform Cannabis Regulation: How Science Can Shape Policy	Clinical Therapeutics	Gillian L. Schauer, L A Dodson et al.	9
3	Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective	Clinical Therapeutics	Julia A. Dilley, Gillian L. Schauer et al.	6
4	Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	International Journal of Drug Policy	David Hammond, Samantha Goodman et al.	68
5	Cannabidiol Marketing Strategies in the United States: An Analysis of Three Prominent Companies	Cannabis and Cannabinoid Research	Carla J. Berg, Gillian L. Schauer et al.	3
6	Clinician Beliefs and Practices Related to Cannabis	Cannabis and Cannabinoid Research	Gillian L. Schauer, Rashid Njai et al.	14
7	Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington	International Journal of Drug Policy	Gillian L. Schauer, Julia A. Dilley et al.	24
8	Use and Perceptions of Cannabidiol Products in Canada and in the United States	Cannabis and Cannabinoid Research	Samantha Goodman, Elle Wadsworth et al.	80
9	Current marijuana use among women of reproductive age	Drug and Alcohol Dependence	Alexander C. Ewing, Gillian L. Schauer et al.	12
10	Point-of-sale marketing and context of marijuana retailers: Assessing reliability and generalizability of the marijuana retail surveillance tool	Preventive Medicine Reports	Carla J. Berg, Lisa Henriksen et al.	19
11	Electronic nicotine delivery system (ENDS) use during smoking cessation: a qualitative study of 40 Oklahoma quitline callers	BMJ Open	Katrina A. Vickerman, Laura A. Beebe et al.	12
12	Marijuana and tobacco co-use among a nationally representative sample of US pregnant and non-pregnant women: 2005–2014 National Survey on Drug Use and Health findings	Drug and Alcohol Dependence	Victoria H. Coleman‐Cowger, Gillian L. Schauer et al.	70
13	Marijuana and tobacco cigarettes: Estimating their behavioral economic relationship using purchasing tasks.	Experimental and Clinical Psychopharmacology	Erica N. Peters, Zachary R. Rosenberry et al.	27
14	Reasons for Electronic Nicotine Delivery System use and smoking abstinence at 6 months: a descriptive study of callers to employer and health plan-sponsored quitlines	Tobacco Control	Katrina A. Vickerman, Gillian L. Schauer et al.	20
15	Public Use of Recreational Marijuana: A Legal Landscape of State Law		Gillian L. Schauer et al.	3
16	Reasons for Polytobacco Use among Young Adults: Scale Development and Validation	Tobacco Prevention & Cessation	Carla J. Berg, Regine Haardöerfer et al.	13
17	Smoking Prevalence and Cessation Characteristics among U.S. Adults With and Without COPD: Findings from the 2011 Behavioral Risk Factor Surveillance System	COPD Journal of Chronic Obstructive Pulmonary Disease	Gillian L. Schauer, Anne G. Wheaton et al.	27
18	A qualitative inquiry about weight counseling practices in community health centers	Patient Education and Counseling	Gillian L. Schauer, Rebecca C. Woodruff et al.	15
19	Gradual Reduction of Cigarette Consumption as a Cessation Strategy: Prevalence, Correlates, and Relationship With Quitting	Nicotine & Tobacco Research	Gillian L. Schauer, Ann Malarcher et al.	7
20	Health professional advice for smoking and weight in adults with and without diabetes: findings from BRFSS	Journal of Behavioral Medicine	Gillian L. Schauer, Abigail C. Halperin et al.	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact